Skip to main content
Clinical Trials/NCT01994876
NCT01994876CompletedNot Applicable

Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy

Coloplast A/S2 sites in 1 country18 target enrollmentStarted: September 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
18
Locations
2
Primary Endpoint
Degree of Leakage

Study Overview

Brief Summary

To investigate the performance and safety of two newly developed convex 1-piece ostomy appliances

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects must comply with the following criteria in order to participate in the investigation:
  • Are at least 18 years of age and have full legal capacity
  • Have had an ileostomy for at least 3 months
  • Have used a convex ostomy appliance for the last month
  • Have given written informed consent
  • Have an ileostomy with a diameter of 33 mm or less
  • Have experience leakage (seeping) under the baseplate at least two times over the last two weeks

Exclusion Criteria

  • Subjects complying with the following criteria must be excluded from participation in the clinical investigation:
  • Have a loop ostomy (also called double-barrel or ostomy with two outlets)
  • Are pregnant or breastfeeding
  • Currently receiving, or have received within the last 2 months, chemotherapy or radiation therapy.
  • Currently receiving or have received, within the last month, systemic or local steroid treatment (adreno-cortical hormone) in the peristomal area
  • Currently suffering from peristomal skin problems (i.e. bleeding or broken skin (weeping skin))
  • Are currently participating in another clinical investigation or has previously participated in this investigation

Outcomes

Primary Outcomes

Degree of Leakage

Time Frame: 14 days

The degree of leakage was measured with a 32-point scale developed by Coloplast A/S, where 0 point represents the best possible outcome (no leakage) and 32 represents the worst possible outcome (full leakage under baseplate)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials